You have a new compound in the early clinical phase. You need to volumetrically assess the market potential of this new compound. Or you might need to assess in which way different clinical outcomes affect market potential of the new therapy. The BASES Rx - Scenario Planner provides critical insights into volume sensitivities for alternative clinical outcomes.

Project design includes monadic evaluation of best case and worse cast scenarios. Additionally, conjoint techniques are used for assessing the sensitivities of alternative clinical outcomes. Customized scenario-planning tools make it easy for you and your team to effectively work with the results.